Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYEli Lilly and Company | 789.394 B USD | 831.54 USD | +4.27% | 7.213 M | 1.24 | 90.96 | 9.14 USD | +68.74% | 0.60% | Health technology | Buy |
NVONovo Nordisk A/S DR | 478.961 B USD | 107.20 USD | −0.40% | 5.223 M | 0.69 | 34.76 | 3.08 USD | +28.16% | 0.96% | Health technology | Buy |
JNJJohnson & Johnson | 374.313 B USD | 155.47 USD | −0.80% | 8.926 M | 1.40 | 25.70 | 6.05 USD | +15.46% | 3.13% | Health technology | Buy |
ABBVAbbVie Inc. | 352.545 B USD | 199.50 USD | −0.50% | 4.597 M | 0.77 | 69.58 | 2.87 USD | −21.52% | 3.11% | Health technology | Buy |
MRKMerck & Company, Inc. | 260.35 B USD | 102.92 USD | +1.73% | 9.208 M | 0.91 | 21.56 | 4.77 USD | +165.21% | 2.99% | Health technology | Buy |
NVSNovartis AG DR | 210.783 B USD | 106.45 USD | −0.59% | 1.177 M | 0.76 | 12.42 | 8.57 USD | +130.62% | 3.00% | Health technology | Neutral |
AZNAstraZeneca PLC DR | 199.37 B USD | 64.49 USD | −0.31% | 10.278 M | 1.22 | 31.25 | 2.06 USD | +4.42% | 2.26% | Health technology | Buy |
PFEPfizer, Inc. | 151.422 B USD | 26.72 USD | −2.69% | 55.951 M | 1.12 | 35.92 | 0.74 USD | −59.14% | 6.25% | Health technology | Buy |
VRTXVertex Pharmaceuticals Incorporated | 133.076 B USD | 516.74 USD | +2.84% | 1.26 M | 1.09 | — | −1.99 USD | −114.96% | 0.00% | Health technology | Buy |
SNYSanofi DR | 130.398 B USD | 51.32 USD | −0.79% | 1.284 M | 0.62 | 28.29 | 1.81 USD | −38.99% | 2.88% | Health technology | Buy |
BMYBristol-Myers Squibb Company | 109.805 B USD | 54.14 USD | −1.04% | 9.219 M | 0.84 | — | −3.60 USD | −191.22% | 4.43% | Health technology | Neutral |
REGNRegeneron Pharmaceuticals, Inc. | 91.035 B USD | 828.42 USD | +0.48% | 563.585 K | 0.64 | 20.50 | 40.41 USD | +15.25% | 0.00% | Health technology | Buy |
ZTSZoetis Inc. | 79.775 B USD | 176.82 USD | +1.47% | 3.243 M | 1.12 | 33.24 | 5.32 USD | +8.17% | 0.98% | Health technology | Buy |
GSKGSK plc DR | 73.151 B USD | 36.29 USD | −1.01% | 8.867 M | 1.03 | 23.61 | 1.54 USD | −57.75% | 4.16% | Health technology | Buy |
TAKTakeda Pharmaceutical Company Limited DR | 43.718 B USD | 13.78 USD | −0.58% | 984.229 K | 0.75 | 22.86 | 0.60 USD | +36.22% | 4.60% | Health technology | Buy |
ALNYAlnylam Pharmaceuticals, Inc. | 35.783 B USD | 277.43 USD | +1.91% | 848.533 K | 0.89 | — | −2.62 USD | +36.82% | 0.00% | Health technology | Buy |
BIIBBiogen Inc. | 25.215 B USD | 173.04 USD | −0.51% | 1.582 M | 0.88 | 15.63 | 11.07 USD | +10.06% | 0.00% | Health technology | Buy |
BGNEBeiGene, Ltd. DR | 22.98 B USD | 205.47 USD | −0.65% | 207.402 K | 0.61 | — | −5.08 USD | +69.54% | 0.00% | Health technology | Strong buy |
UTHRUnited Therapeutics Corporation | 18.304 B USD | 410.00 USD | +1.85% | 498.743 K | 1.27 | 18.01 | 22.77 USD | +25.44% | 0.00% | Health technology | Buy |
INCYIncyte Corporation | 16.063 B USD | 83.38 USD | +1.26% | 3.236 M | 1.29 | 590.51 | 0.14 USD | −92.50% | 0.00% | Health technology | Buy |
VTRSViatris Inc. | 15.469 B USD | 12.96 USD | −1.67% | 8.943 M | 1.18 | — | −0.74 USD | −148.99% | 3.70% | Health technology | Neutral |
RPRXRoyalty Pharma plc | 15.454 B USD | 26.21 USD | −1.17% | 5.979 M | 2.68 | 10.25 | 2.56 USD | +538.81% | 3.17% | Health technology | Strong buy |
GMABGenmab A/S DR | 15.192 B USD | 23.08 USD | −0.13% | 1.561 M | 1.08 | 22.23 | 1.04 USD | +10.05% | 0.00% | Health technology | Buy |
INSMInsmed Incorporated | 13.157 B USD | 73.54 USD | +2.58% | 1.122 M | 0.77 | — | −5.56 USD | −5.41% | 0.00% | Health technology | Strong buy |
NBIXNeurocrine Biosciences, Inc. | 12.731 B USD | 125.74 USD | +1.42% | 561.776 K | 0.47 | 33.69 | 3.73 USD | +99.71% | 0.00% | Health technology | Strong buy |
RDYDr. Reddy's Laboratories Ltd DR | 12.678 B USD | 15.11 USD | +0.13% | 483.137 K | 0.70 | 19.70 | 0.77 USD | +3.36% | 0.53% | Health technology | Neutral |
SRPTSarepta Therapeutics, Inc. | 11.616 B USD | 121.61 USD | +0.99% | 1.485 M | 1.50 | 101.02 | 1.20 USD | — | 0.00% | Health technology | Strong buy |
CTLTCatalent, Inc. | 10.784 B USD | 59.41 USD | −0.85% | 2.565 M | 1.25 | — | −2.27 USD | +58.54% | 0.00% | Health technology | Neutral |
EXELExelixis, Inc. | 10.352 B USD | 36.25 USD | +1.26% | 2.228 M | 0.71 | 23.10 | 1.57 USD | +459.23% | 0.00% | Health technology | Buy |
ITCIIntra-Cellular Therapies Inc. | 9.678 B USD | 91.29 USD | +0.86% | 585.634 K | 0.67 | — | −0.86 USD | +47.14% | 0.00% | Health technology | Strong buy |
ROIVRoivant Sciences Ltd. | 8.778 B USD | 11.87 USD | +0.94% | 2.997 M | 0.91 | 2.13 | 5.57 USD | — | 0.00% | Health technology | Strong buy |
RGENRepligen Corporation | 7.88 B USD | 140.70 USD | −2.21% | 543.9 K | 1.30 | — | −0.04 USD | −101.72% | 0.00% | Health technology | Strong buy |
MDGLMadrigal Pharmaceuticals, Inc. | 7.649 B USD | 350.70 USD | −1.17% | 454.434 K | 0.52 | — | −25.07 USD | −30.31% | 0.00% | Health technology | Buy |
VKTXViking Therapeutics, Inc. | 7.631 B USD | 68.48 USD | −0.54% | 3.88 M | 0.50 | — | −0.94 USD | −1.31% | 0.00% | Health technology | Strong buy |
GRFSGrifols, S.A. DR | 7.561 B USD | 9.49 USD | −0.11% | 1.408 M | 1.31 | — | — | — | 0.00% | Health technology | Neutral |
JAZZJazz Pharmaceuticals plc | 7.473 B USD | 123.61 USD | +3.80% | 868.107 K | 1.45 | 17.80 | 6.94 USD | +1,051.97% | 0.00% | Health technology | Buy |
LEGNLegend Biotech Corporation DR | 7.332 B USD | 40.03 USD | −2.25% | 2.584 M | 1.78 | — | −1.57 USD | +50.42% | 0.00% | Health technology | Strong buy |
ASNDAscendis Pharma A/S DR | 7.13 B USD | 124.33 USD | −1.75% | 459.304 K | 1.38 | — | −9.34 USD | +17.33% | 0.00% | Health technology | Strong buy |
CYTKCytokinetics, Incorporated | 6.842 B USD | 57.98 USD | +3.83% | 1.72 M | 1.58 | — | −5.39 USD | +2.40% | 0.00% | Health technology | Buy |
CORTCorcept Therapeutics Incorporated | 6.245 B USD | 59.60 USD | +9.76% | 1.728 M | 1.37 | 47.40 | 1.26 USD | +55.35% | 0.00% | Health technology | Strong buy |
IONSIonis Pharmaceuticals, Inc. | 6.188 B USD | 39.19 USD | +1.90% | 1.019 M | 0.94 | — | −2.44 USD | +14.63% | 0.00% | Health technology | Buy |
CRNXCrinetics Pharmaceuticals, Inc. | 5.464 B USD | 60.69 USD | +1.47% | 573.323 K | 1.11 | — | −3.77 USD | −10.61% | 0.00% | Health technology | Strong buy |
BHVNBiohaven Ltd. | 5.398 B USD | 53.47 USD | +0.72% | 679.774 K | 1.05 | — | −9.16 USD | −44.95% | 0.00% | Health technology | Strong buy |
ALKSAlkermes plc | 4.67 B USD | 28.86 USD | −0.38% | 1.837 M | 1.04 | 14.70 | 1.96 USD | +59.05% | 0.00% | Health technology | Buy |
RAREUltragenyx Pharmaceutical Inc. | 4.65 B USD | 50.36 USD | −0.14% | 1.247 M | 1.18 | — | −6.46 USD | +28.02% | 0.00% | Health technology | Strong buy |
TGTXTG Therapeutics, Inc. | 4.485 B USD | 28.81 USD | +3.26% | 3.347 M | 0.86 | — | −0.11 USD | +60.71% | 0.00% | Health technology | Buy |
OGNOrganon & Co. | 4.131 B USD | 16.04 USD | −0.50% | 2.57 M | 0.69 | 3.18 | 5.04 USD | +120.60% | 6.98% | Health technology | Neutral |
PBHPrestige Consumer Healthcare Inc. | 3.971 B USD | 80.37 USD | +0.35% | 367.423 K | 1.34 | 19.58 | 4.11 USD | — | 0.00% | Health technology | Buy |
IBRXImmunityBio, Inc. | 3.88 B USD | 5.57 USD | +5.09% | 5.617 M | 0.37 | — | −0.93 USD | +17.43% | 0.00% | Health technology | Buy |
APLSApellis Pharmaceuticals, Inc. | 3.729 B USD | 29.98 USD | +4.31% | 4.756 M | 1.28 | — | −2.04 USD | +61.20% | 0.00% | Health technology | Buy |
PRGOPerrigo Company plc | 3.596 B USD | 26.36 USD | −2.12% | 1.634 M | 0.88 | — | −1.11 USD | −34,712.50% | 4.18% | Health technology | Strong buy |
PTCTPTC Therapeutics, Inc. | 3.415 B USD | 44.28 USD | +3.07% | 1.019 M | 1.61 | — | −5.94 USD | +31.43% | 0.00% | Health technology | Neutral |
XENEXenon Pharmaceuticals Inc. | 3.409 B USD | 45.00 USD | −1.62% | 332.239 K | 0.97 | — | −2.74 USD | −9.82% | 0.00% | Health technology | Strong buy |
AGIOAgios Pharmaceuticals, Inc. | 3.368 B USD | 59.06 USD | +7.23% | 1.692 M | 2.46 | 5.20 | 11.37 USD | — | 0.00% | Health technology | Buy |
MLTXMoonLake Immunotherapeutics | 3.317 B USD | 51.78 USD | +2.19% | 195.056 K | 0.72 | — | −1.29 USD | −36.77% | 0.00% | Health technology | Strong buy |
FOLDAmicus Therapeutics, Inc. | 3.284 B USD | 10.99 USD | +0.09% | 2.097 M | 0.80 | — | −0.35 USD | +41.95% | 0.00% | Health technology | Strong buy |
HCMHUTCHMED (China) Limited DR | 3.179 B USD | 17.95 USD | −4.01% | 85.779 K | 1.07 | — | −0.25 USD | +67.34% | 0.00% | Health technology | Strong buy |
VRNAVerona Pharma plc DR | 3.157 B USD | 38.58 USD | +1.05% | 1.196 M | 1.10 | — | −1.94 USD | −197.56% | 0.00% | Health technology | Strong buy |
ACADACADIA Pharmaceuticals Inc. | 2.938 B USD | 17.66 USD | +2.67% | 1.534 M | 0.99 | 22.86 | 0.77 USD | — | 0.00% | Health technology | Buy |
CPRXCatalyst Pharmaceuticals, Inc. | 2.854 B USD | 23.93 USD | +2.92% | 1.589 M | 1.71 | 20.42 | 1.17 USD | +122.28% | 0.00% | Health technology | Strong buy |
KROSKeros Therapeutics, Inc. | 2.751 B USD | 67.91 USD | +1.10% | 624.526 K | 1.72 | — | −5.21 USD | −5.26% | 0.00% | Health technology | Strong buy |
IDYAIDEAYA Biosciences, Inc. | 2.704 B USD | 31.28 USD | +4.30% | 696.273 K | 0.88 | — | −2.33 USD | −19.54% | 0.00% | Health technology | Strong buy |
AMRXAmneal Pharmaceuticals, Inc. | 2.702 B USD | 8.73 USD | +1.39% | 1.72 M | 1.64 | — | −0.68 USD | −1,181.67% | 0.00% | Health technology | Buy |
VCELVericel Corporation | 2.665 B USD | 54.00 USD | +7.94% | 645.36 K | 1.44 | 864.00 | 0.06 USD | — | 0.00% | Health technology | Strong buy |
BLTEBelite Bio, Inc DR | 2.482 B USD | 81.08 USD | −1.59% | 127.118 K | 1.02 | — | −1.23 USD | — | 0.00% | Health technology | Strong buy |
SLNOSoleno Therapeutics, Inc. | 2.46 B USD | 57.05 USD | −0.11% | 513.19 K | 0.98 | — | −3.31 USD | −2.66% | 0.00% | Health technology | Strong buy |
AKROAkero Therapeutics, Inc. | 2.392 B USD | 34.45 USD | −1.20% | 811.496 K | 1.29 | — | −3.75 USD | −59.03% | 0.00% | Health technology | Strong buy |
AMPHAmphastar Pharmaceuticals, Inc. | 2.323 B USD | 48.31 USD | +4.82% | 626.887 K | 1.57 | 16.07 | 3.01 USD | +17.33% | 0.00% | Health technology | Buy |
NAMSNewAmsterdam Pharma Company N.V. | 2.228 B USD | 24.12 USD | +6.54% | 598.861 K | 1.63 | — | — | — | 0.00% | Health technology | Strong buy |
LGNDLigand Pharmaceuticals Incorporated | 2.215 B USD | 121.25 USD | −6.66% | 260.623 K | 1.85 | 48.24 | 2.51 USD | +200.39% | 0.00% | Health technology | Strong buy |
NMRANeumora Therapeutics, Inc. | 2.167 B USD | 13.54 USD | +3.99% | 1.272 M | 1.08 | — | −1.74 USD | −100.60% | 0.00% | Health technology | Strong buy |
HRMYHarmony Biosciences Holdings, Inc. | 2.058 B USD | 36.08 USD | +3.35% | 845.073 K | 0.44 | 17.08 | 2.11 USD | −14.38% | 0.00% | Health technology | Buy |
MNKDMannKind Corporation | 2.026 B USD | 7.35 USD | −0.61% | 4.823 M | 1.59 | 104.48 | 0.07 USD | — | 0.00% | Health technology | Strong buy |
SUPNSupernus Pharmaceuticals, Inc. | 2.021 B USD | 36.60 USD | +0.55% | 578.65 K | 1.13 | 34.27 | 1.07 USD | +175.07% | 0.00% | Health technology | Buy |
MIRMMirum Pharmaceuticals, Inc. | 2.004 B USD | 42.00 USD | +2.24% | 367.686 K | 1.30 | — | −2.34 USD | +50.73% | 0.00% | Health technology | Strong buy |
NRIXNurix Therapeutics, Inc. | 1.937 B USD | 27.34 USD | +0.37% | 806.669 K | 0.69 | — | −2.91 USD | −5.94% | 0.00% | Health technology | Strong buy |
VRDNViridian Therapeutics, Inc. | 1.925 B USD | 25.21 USD | +2.02% | 889.409 K | 1.21 | — | −4.25 USD | +12.78% | 0.00% | Health technology | Strong buy |
TARSTarsus Pharmaceuticals, Inc. | 1.88 B USD | 49.42 USD | +5.62% | 1.037 M | 0.87 | — | −4.48 USD | −31.81% | 0.00% | Health technology | Strong buy |
CNTACentessa Pharmaceuticals plc DR | 1.867 B USD | 16.50 USD | +2.23% | 598.945 K | 2.16 | — | −1.56 USD | +14.73% | 0.00% | Health technology | Strong buy |
HROWHarrow, Inc. | 1.863 B USD | 52.51 USD | +5.21% | 467.677 K | 0.88 | — | −0.95 USD | −70.23% | 0.00% | Health technology | Strong buy |
OCULOcular Therapeutix, Inc. | 1.731 B USD | 11.10 USD | +2.97% | 854.897 K | 0.95 | — | −1.35 USD | −15.49% | 0.00% | Health technology | Strong buy |
DAWNDay One Biopharmaceuticals, Inc. | 1.653 B USD | 16.39 USD | +4.00% | 2.374 M | 1.60 | — | −1.01 USD | +55.62% | 0.00% | Health technology | Strong buy |
SPRYARS Pharmaceuticals, Inc. | 1.652 B USD | 17.04 USD | +5.58% | 1.499 M | 1.72 | — | −0.47 USD | +81.88% | 0.00% | Health technology | Strong buy |
KNSAKiniksa Pharmaceuticals, Ltd. | 1.651 B USD | 22.86 USD | −0.65% | 353.8 K | 0.81 | — | −0.14 USD | −32.91% | 0.00% | Health technology | Strong buy |
TVTXTravere Therapeutics, Inc. | 1.549 B USD | 19.85 USD | +12.40% | 3.982 M | 2.93 | — | −4.56 USD | −3.48% | 0.00% | Health technology | Strong buy |
AVDLAvadel Pharmaceuticals plc | 1.535 B USD | 15.94 USD | +1.40% | 970.242 K | 0.80 | — | −1.15 USD | +44.80% | 0.00% | Health technology | Strong buy |
EVOEvotec SE DR | 1.463 B USD | 4.13 USD | −2.82% | 188.542 K | 0.64 | — | −0.52 USD | +5.42% | 0.00% | Health technology | Buy |
PRAXPraxis Precision Medicines, Inc. | 1.451 B USD | 77.88 USD | +3.35% | 317.65 K | 0.94 | — | −10.30 USD | +69.41% | 0.00% | Health technology | Strong buy |
GYREGyre Therapeutics, Inc. | 1.431 B USD | 15.32 USD | +1.73% | 34.811 K | 0.98 | — | — | — | 0.00% | Health technology | — |
INDVIndivior PLC | 1.314 B USD | 10.25 USD | −5.27% | 1.474 M | 1.24 | — | −0.04 USD | +97.57% | 0.00% | Health technology | Strong buy |
BBCAXBicara Therapeutics Inc. | 1.295 B USD | 23.82 USD | +0.93% | 178.233 K | 0.58 | — | — | — | 0.00% | Health technology | Strong buy |
ARQTArcutis Biotherapeutics, Inc. | 1.266 B USD | 10.82 USD | +4.04% | 4.257 M | 1.82 | — | −1.79 USD | +59.00% | 0.00% | Health technology | Strong buy |
INVAInnoviva, Inc. | 1.263 B USD | 20.18 USD | +0.90% | 695.692 K | 1.67 | 29.34 | 0.69 USD | +55.68% | 0.00% | Health technology | Buy |
PHVSPharvaris N.V. | 1.221 B USD | 22.61 USD | +1.30% | 23.35 K | 0.27 | — | −2.46 USD | +13.46% | 0.00% | Health technology | Strong buy |
ARDXArdelyx, Inc. | 1.201 B USD | 5.07 USD | −20.53% | 17.431 M | 4.06 | — | −0.31 USD | −149.72% | 0.00% | Health technology | Strong buy |
APLTApplied Therapeutics, Inc. | 1.174 B USD | 10.09 USD | +3.59% | 2.072 M | 1.23 | — | — | — | 0.00% | Health technology | Strong buy |
ZYMEZymeworks Inc. | 1.155 B USD | 16.63 USD | −0.83% | 678.74 K | 1.03 | — | −1.51 USD | −148.37% | 0.00% | Health technology | Buy |
PHATPhathom Pharmaceuticals, Inc. | 1.153 B USD | 16.86 USD | −8.86% | 1.26 M | 1.30 | — | −5.69 USD | −48.61% | 0.00% | Health technology | Strong buy |
AVBPArriVent BioPharma, Inc. | 1.148 B USD | 34.19 USD | −4.04% | 197.75 K | 1.56 | — | −2.24 USD | −33.83% | 0.00% | Health technology | Strong buy |
ETNB89bio, Inc. | 1.109 B USD | 10.45 USD | +4.92% | 760.377 K | 0.95 | — | −2.91 USD | −45.57% | 0.00% | Health technology | Buy |